{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:55:22Z","timestamp":1776084922123,"version":"3.50.1"},"reference-count":86,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Irritable bowel syndrome (IBS) is prevalent and can be disabling. Many patients remain symptomatic despite behavioral and medical therapies. Psychedelic-assisted therapy (PAT), in which serotonergic agents like psilocybin are administered in a psychotherapeutic context, has shown promise for refractory psychiatric disorders, including major depressive disorder and post-traumatic stress disorder. Emerging evidence suggests PAT may also be beneficial for chronic pain conditions, including fibromyalgia, low back pain, and migraines. IBS is highly comorbid with depression, anxiety, and other chronic pain disorders, suggesting shared cognitive and neurological roots and potentially shared therapeutic targets. In this editorial, we discuss 3 lines of evidence for PAT as a treatment for IBS, under the overarching themes of (1) psychological mechanisms (the findings from historic studies of psychedelics for chronic pain and the elements of psychobiological dysfunction targeted by PAT), (2) central nervous system mechanisms (default mode network modulation and induction of neuroplasticity), and (3) the neurointestinal pathophysiology of IBS that may be modified by PAT. We argue that this evidence suggests PAT is worthy of study as a new therapy for IBS, and potentially for other disorders of gut-brain interaction (DGBI). Successful application of PAT to gastrointestinal disease would represent a major step beyond mind-body dualism, with potential implications for other functional somatic disorders.<\/jats:p>","DOI":"10.1097\/mcg.0000000000002149","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T18:00:18Z","timestamp":1740506418000},"page":"385-392","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome"],"prefix":"10.1097","volume":"59","author":[{"given":"Erin","family":"Mauney","sequence":"first","affiliation":[{"name":"Pediatric Gastroenterology and Nutrition Program, Massachusetts General Hospital for Children"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franklin","family":"King","sequence":"additional","affiliation":[{"name":"Center for the Neuroscience of Psychedelics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Burton-Murray","sequence":"additional","affiliation":[{"name":"Center for Neurointestinal Health, Massachusetts General Hospital, Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Braden","family":"Kuo","sequence":"additional","affiliation":[{"name":"Center for Neurointestinal Health, Massachusetts General Hospital, Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,5]]},"reference":[{"key":"R1-20250407","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"R2-20250407","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG clinical guideline: management of irritable bowel syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"R3-20250407","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3389\/fpsyt.2019.00714","article-title":"High rates of non-response across treatment attempts in chronic irritable bowel syndrome: results from a follow-up study in tertiary care","volume":"10","author":"Dong","year":"2019","journal-title":"Front Psychiatry"},{"key":"R4-20250407","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/S0016-5085(22)00537-6","article-title":"Spotlight: IBS treatment","volume":"163","author":"Chang","year":"2022","journal-title":"Gastroenterology"},{"key":"R5-20250407","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.gastro.2022.04.017","article-title":"AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with diarrhea","volume":"163","author":"Lembo","year":"2022","journal-title":"Gastroenterology"},{"key":"R6-20250407","doi-asserted-by":"crossref","first-page":"1389911","DOI":"10.3389\/fpsyg.2024.1389911","article-title":"Gut-directed hypnosis and hypnotherapy for irritable bowel syndrome: a mini-review","volume":"15","author":"H\u00e4user","year":"2024","journal-title":"Front Psychol"},{"key":"R7-20250407","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.psy.0000163457.32382.ac","article-title":"Reported sexual abuse predicts impaired functioning but a good response to psychological treatments in patients with severe irritable bowel syndrome","volume":"67","author":"Creed","year":"2005","journal-title":"Psychosom Med"},{"key":"R8-20250407","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","article-title":"Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms","volume":"73","author":"Inserra","year":"2021","journal-title":"Pharmacol Rev"},{"key":"R10-20250407","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/02698811211008554","article-title":"Psychedelics and health behaviour change","volume":"36","author":"Teixeira","year":"2022","journal-title":"J Psychopharmacol"},{"key":"R11-20250407","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/rapm-2020-101273","article-title":"Chronic pain and psychedelics: a review and proposed mechanism of action","volume":"45","author":"Castellanos","year":"2020","journal-title":"Reg Anesth Pain Med"},{"key":"R12-20250407","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1213\/00000539-196405000-00013","article-title":"Study of lysergic acid diethylamide as an analgesic agent","volume":"43","author":"Kast","year":"1964","journal-title":"Anesth Analg"},{"key":"R13-20250407","first-page":"121","article-title":"LSD-assisted psychotherapy and the human encounter with death","volume":"4","author":"Richards","year":"1972","journal-title":"J Transpers Psychol"},{"key":"R14-20250407","first-page":"69","article-title":"The psychedelic experience\u2014a new concept in psychotherapy","volume":"4","author":"Sherwood","year":"1962","journal-title":"J Neuropsychiatr"},{"key":"R15-20250407","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/bjc\/azn074","article-title":"Moral panic: its origins in resistance, ressentiment and the translation of fantasy into reality","volume":"49","author":"Young","year":"2009","journal-title":"Br J Criminol"},{"key":"R16-20250407","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"R17-20250407","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ijnp\/pyac075","article-title":"Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy participants","volume":"26","author":"Becker","year":"2023","journal-title":"Int J Neuropsychopharmacol"},{"key":"R18-20250407","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J Psychopharmacol"},{"key":"R19-20250407","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"R20-20250407","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/s41591-023-02455-9","article-title":"Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study","volume":"29","author":"Peck","year":"2023","journal-title":"Nat Med"},{"key":"R21-20250407","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R22-20250407","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","article-title":"MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial","volume":"29","author":"Mitchell","year":"2023","journal-title":"Nat Med"},{"key":"R23-20250407","doi-asserted-by":"crossref","first-page":"1040217","DOI":"10.3389\/fpsyt.2022.1040217","article-title":"Therapeutic use of psilocybin: practical considerations for dosing and administration","volume":"13","author":"MacCallum","year":"2022","journal-title":"Front Psychiatry"},{"key":"R26-20250407","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s13311-020-00962-y","article-title":"Exploratory controlled study of the migraine-suppressing effects of psilocybin","volume":"18","author":"Schindler","year":"2021","journal-title":"Neurotherapeutics"},{"key":"R28-20250407","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jad.2022.09.168","article-title":"Psychedelic therapy for depressive symptoms: a systematic review and meta-analysis","volume":"322","author":"Ko","year":"2023","journal-title":"J Affect Disord"},{"key":"R29-20250407","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jad.2019.07.076","article-title":"Classical psychedelics for the treatment of depression and anxiety: a systematic review","volume":"258","author":"Muttoni","year":"2019","journal-title":"J Affect Disord"},{"key":"R30-20250407","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1017\/S0033291716001987","article-title":"A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset","volume":"46","author":"Sibelli","year":"2016","journal-title":"Psychol Med"},{"key":"R31-20250407","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","article-title":"Ketamine versus ECT for nonpsychotic treatment-resistant major depression","volume":"388","author":"Anand","year":"2023","journal-title":"N Engl J Med"},{"key":"R32-20250407","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N Engl J Med"},{"key":"R33-20250407","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat Med"},{"key":"R34-20250407","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/apt.15325","article-title":"Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome","volume":"50","author":"Zamani","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R35-20250407","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0022167817709585","article-title":"Patients\u2019 accounts of increased \u201cConnectedness\u201d and \u201cAcceptance\u201d after psilocybin for treatment-resistant depression","volume":"57","author":"Watts","year":"2017","journal-title":"J Humanist Psychol"},{"key":"R36-20250407","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/ibd\/izz032","article-title":"Initial assessment of post-traumatic stress in a US cohort of inflammatory bowel disease patients","volume":"25","author":"Taft","year":"2019","journal-title":"Inflammat Bowel Dis"},{"key":"R37-20250407","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1017\/S0033291723001514","article-title":"Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression","volume":"54","author":"Weiss","year":"2024","journal-title":"Psychol Med"},{"key":"R38-20250407","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jpsychores.2013.03.004","article-title":"Which psychological factors exacerbate irritable bowel syndrome? Development of a comprehensive model","volume":"74","author":"van Tilburg","year":"2013","journal-title":"J Psychosom Res"},{"key":"R39-20250407","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5056\/jnm16220","article-title":"The increased level of depression and anxiety in irritable bowel syndrome patients compared with healthy controls: systematic review and meta-analysis","volume":"23","author":"Lee","year":"2017","journal-title":"J Neurogastroenterol Motil"},{"key":"R40-20250407","first-page":"959","article-title":"Five personality dimensions in patients with irritable bowel syndrome","volume":"4","author":"Farnam","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R41-20250407","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcbs.2019.11.004","article-title":"Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety","volume":"15","author":"Davis","year":"2020","journal-title":"J Contextual Behav Sci"},{"key":"R42-20250407","doi-asserted-by":"crossref","first-page":"8833","DOI":"10.1038\/s41598-024-58318-x","article-title":"Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial","volume":"14","author":"Sloshower","year":"2024","journal-title":"Sci Rep"},{"key":"R43-20250407","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/09540261.2018.1474088","article-title":"Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy","volume":"30","author":"Walsh","year":"2018","journal-title":"Int Rev Psychiatry"},{"key":"R44-20250407","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/2049463720926559","article-title":"Preliminary investigation of the associations between psychological flexibility, symptoms and daily functioning in people with chronic abdominal pain","volume":"15","author":"Yu","year":"2021","journal-title":"Br J Pain"},{"key":"R45-20250407","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.gastro.2021.09.015","article-title":"A Rome working team report on brain-gut behavior therapies for disorders of gut-brain interaction","volume":"162","author":"Keefer","year":"2022","journal-title":"Gastroenterology"},{"key":"R46-20250407","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.3390\/jcm11216516","article-title":"Meditation and irritable bowel syndrome, a systematic review and meta-analysis","volume":"11","author":"Babos","year":"2022","journal-title":"J Clin Med"},{"key":"R47-20250407","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychores.2014.03.006","article-title":"Cognitive-behavioral therapy for irritable bowel syndrome: a meta-analysis","volume":"77","author":"Li","year":"2014","journal-title":"J Psychosom Res"},{"key":"R48-20250407","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12876-024-03142-w","article-title":"Comparing the effectiveness of transdiagnostic treatment with acceptance and commitment therapy on emotional disorders, rumination, and life satisfaction in patients with irritable bowel syndrome: a randomized clinical trial","volume":"24","author":"Shahkaram","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"R49-20250407","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2174\/1570159X22666231027111147","article-title":"The psychedelic future of post-traumatic stress disorder treatment","volume":"22","author":"Zaretsky","year":"2024","journal-title":"Curr Neuropharmacol"},{"key":"R50-20250407","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide-assisted therapy in patients with anxiety with and without a life-threatening illness: a randomized, double-blind, placebo-controlled phase II study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol Psychiatry"},{"key":"R51-20250407","doi-asserted-by":"crossref","first-page":"661233","DOI":"10.3389\/fpsyt.2021.661233","article-title":"Does psychedelic therapy have a transdiagnostic action and prophylactic potential?","volume":"12","author":"Ko\u010d\u00e1rov\u00e1","year":"2021","journal-title":"Front Psychiatry"},{"key":"R52-20250407","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41380-023-01972-w","article-title":"The neurobiology of irritable bowel syndrome","volume":"28","author":"Mayer","year":"2023","journal-title":"Mol Psychiatry"},{"key":"R53-20250407","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41386-019-0569-3","article-title":"Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects","volume":"45","author":"Holze","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"R54-20250407","first-page":"120","article-title":"A high-resolution in vivo atlas of the human brain\u2019s serotonin system","volume":"37","author":"Beliveau","year":"2017","journal-title":"J Neurosci"},{"key":"R55-20250407","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41398-019-0560-0","article-title":"Repetitive negative thinking in daily life and functional connectivity among default mode, fronto-parietal, and salience networks","volume":"9","author":"Lydon-Staley","year":"2019","journal-title":"Transl Psychiatry"},{"key":"R56-20250407","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/PSY.0000000000000089","article-title":"Early adverse life events and resting state neural networks in patients with chronic abdominal pain: evidence for sex differences","volume":"76","author":"Gupta","year":"2014","journal-title":"Psychosom Med"},{"key":"R57-20250407","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1007\/s12035-015-9558-7","article-title":"Topological reorganization of the default mode network in irritable bowel syndrome","volume":"53","author":"Qi","year":"2016","journal-title":"Mol Neurobiol"},{"key":"R58-20250407","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/s41380-021-01375-9","article-title":"A neuropsychosocial signature predicts longitudinal symptom changes in women with irritable bowel syndrome","volume":"27","author":"Bhatt","year":"2022","journal-title":"Mol Psychiatry"},{"key":"R59-20250407","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"R60-20250407","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep"},{"key":"R61-20250407","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat Neurosci"},{"issue":"supplement","key":"R62-20250407","first-page":"51","article-title":"BDNF\/TRKB SNPs in individuals with IBS; associations with pain and psychological symptoms in U.S. and UKBB cohorts","volume":"24","author":"Weaver-Toedtman","year":"2023","journal-title":"JPain"},{"key":"R63-20250407","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ejp.2171","article-title":"Potential analgesic effects of psychedelics on select chronic pain conditions: a survey study","volume":"28","author":"Cavarra","year":"2024","journal-title":"Eur J Pain"},{"key":"R64-20250407","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/0269881120940937","article-title":"A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers","volume":"35","author":"Ramaekers","year":"2021","journal-title":"J Psychopharmacol"},{"key":"R65-20250407","doi-asserted-by":"crossref","first-page":"R1282","DOI":"10.1016\/j.cub.2023.10.016","article-title":"Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain","volume":"33","author":"Kolbman","year":"2023","journal-title":"Curr Biol"},{"key":"R66-20250407","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol Rev"},{"key":"R67-20250407","doi-asserted-by":"crossref","first-page":"116980","DOI":"10.1016\/j.neuroimage.2020.116980","article-title":"Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention","volume":"218","author":"Barrett","year":"2020","journal-title":"Neuroimage"},{"key":"R68-20250407","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0269881118754710","article-title":"Psychedelics and the essential importance of context","volume":"32","author":"Carhart-Harris","year":"2018","journal-title":"J Psychopharmacol"},{"key":"R69-20250407","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J Psychopharmacol"},{"key":"R70-20250407","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tins.2006.11.002","article-title":"5-HT in the enteric nervous system: gut function and neuropharmacology","volume":"30","author":"McLean","year":"2007","journal-title":"Trends Neurosci"},{"key":"R71-20250407","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5056\/jnm14157","article-title":"Distribution of 5-HT3, 5-HT4, and 5-HT7 receptors along the human colon","volume":"21","author":"Yaakob","year":"2015","journal-title":"J Neurogastroenterol Motil"},{"key":"R72-20250407","doi-asserted-by":"crossref","first-page":"G877","DOI":"10.1152\/ajpgi.00435.2001","article-title":"5-HT(2A) receptors: location and functional analysis in intestines of wild-type and 5-HT(2A) knockout mice","volume":"282","author":"Fiorica-Howells","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R73-20250407","doi-asserted-by":"crossref","first-page":"e9019","DOI":"10.1371\/journal.pone.0009019","article-title":"Psychedelics and the human receptorome","volume":"5","author":"Ray","year":"2010","journal-title":"PLoS One"},{"key":"R74-20250407","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.2174\/1381612826666200612161542","article-title":"Serotonergic integration in the intestinal mucosa","volume":"26","author":"Wood","year":"2020","journal-title":"Curr Pharm Des"},{"key":"R75-20250407","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2004.03.013","article-title":"Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome","volume":"126","author":"Coates","year":"2004","journal-title":"Gastroenterology"},{"key":"R76-20250407","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrgastro.2013.105","article-title":"Serotonin signalling in the gut\u2013functions, dysfunctions and therapeutic targets","volume":"10","author":"Mawe","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R77-20250407","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.cub.2021.02.049","article-title":"Vagus nerve stimulation induces widespread cortical and behavioral activation","volume":"31","author":"Collins","year":"2021","journal-title":"Curr Biol"},{"key":"R78-20250407","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.3390\/ijms24043543","article-title":"Peripheral regulation of central brain-derived neurotrophic factor expression through the vagus nerve","volume":"24","author":"Amagase","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R79-20250407","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tips.2023.12.007","article-title":"Do the therapeutic effects of psilocybin involve actions in the gut?","volume":"45","author":"Reed","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"R80-20250407","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fcvm.2017.00048","article-title":"The effects of serotonin in immune cells","volume":"4","author":"Herr","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"R81-20250407","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2147\/JIR.S174982","article-title":"The role of inflammation in irritable bowel syndrome (IBS)","volume":"11","author":"Ng","year":"2018","journal-title":"J Inflamm Res"},{"key":"R82-20250407","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1016\/j.cell.2023.09.013","article-title":"Serotonin reduction in post-acute sequelae of viral infection","volume":"186","author":"Wong","year":"2023","journal-title":"Cell"},{"key":"R83-20250407","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrgastro.2010.4","article-title":"Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions","volume":"7","author":"Ohman","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R84-20250407","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/09540261.2018.1481827","article-title":"Psychedelics as anti-inflammatory agents","volume":"30","author":"Flanagan","year":"2018","journal-title":"Int Rev Psychiatry"},{"key":"R85-20250407","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3390\/cells11081362","article-title":"Mechanistic insights into the link between gut dysbiosis and major depression: an extensive review","volume":"11","author":"Sonali","year":"2022","journal-title":"Cells"},{"key":"R86-20250407","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/bph.15977","article-title":"Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome","volume":"180","author":"Inserra","year":"2023","journal-title":"Br J Pharmacol"},{"key":"R87-20250407","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.biopsych.2023.07.019","article-title":"Psycho-pharmacomicrobiomics: a systematic review and meta-analysis","volume":"95","author":"Minichino","year":"2024","journal-title":"Biol Psychiatry"},{"key":"R88-20250407","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/a-1524-2794","article-title":"Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports","volume":"54","author":"Nayak","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"R89-20250407","first-page":"655","article-title":"Irritable bowel syndrome may be induced by decreased neuroplasticity","volume":"35","author":"Zheng","year":"2014","journal-title":"Neuro Endocrinol Lett"},{"key":"R90-20250407","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S2215-0366(18)30135-4","article-title":"3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial","volume":"5","author":"Mithoefer","year":"2018","journal-title":"Lancet Psychiatry"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCG.0000000000002149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T19:51:50Z","timestamp":1744055510000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCG.0000000000002149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":86,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0000000000002149","relation":{},"ISSN":["1539-2031"],"issn-type":[{"value":"1539-2031","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]}}}